Serum 25-Hydroxyvitamin D Levels and Prognosis in Hematological Malignancies: A Systematic Review and Meta-Analysis | Zendy

Wei Wang | Zendy; Guangyun Li | Zendy; Xiaoyan He | Zendy; Jian Gao | Zendy; Robin Wang | Zendy; Yangang Wang | Zendy; Wenjuan Zhao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum 25-Hydroxyvitamin D Levels and Prognosis in Hematological Malignancies: A Systematic Review and Meta-Analysis

Author(s) -

Wei Wang,

Guangyun Li,

Xiaoyan He,

Jian Gao,

Robin Wang,

Yangang Wang,

Wenjuan Zhao

Publication year - 2015

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000374007

Subject(s) - medicine , meta analysis , hazard ratio , gastroenterology , subgroup analysis , confidence interval , colorectal cancer , lymphoma , cancer , breast cancer , leukemia , hematology , oncology

Serum 25-hydroxyvitamin D [25(OH)D] levels proved to be associated with prognosis of patients with colorectal cancer or breast cancer, but its prognostic role in hematological malignancies was still unclear. A systematic review and meta-analysis was performed to comprehensively evaluate the association between serum 25(OH)D levels and prognosis of patients with hematological malignancies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research